Anti-Human CD54 (ICAM-1) Functional Grade Purified

Also known as: Intercellular adhesion molecule-1, ICAM1

Clone: HA58

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 16-0549

Cat. No. Size
16-0549-82 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD54 (ICAM-1) Functional Grade Purified.

Staining of normal human peripheral blood cells with Anti-Human CD54 (ICAM-1) PE. Appropriate...View More

  • Data for Anti-Human CD54 (ICAM-1) Functional Grade Purified.
Description

Description: The HA58 monoclonal antibody reacts with human CD54 (InterCellular Adhesion Molecule-1, ICAM-1), a 90-110 kDa transmembrane glycoprotein expressed by monocytes, lymphocytes and endothelial cells. Expression of CD54 is upregulated on activated lymphocytes. Interaction of CD54 with its ligand CD11a is important in the inflammatory response.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate Functional Grade Purified (low endotoxin, azide-free)
Reported Applications Flow Cytometric Analysis, Functional Assays
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-0549 Anti-Human CD54 (ICAM-1) Biotin FC RUO
17-0549 Anti-Human CD54 (ICAM-1) APC 633 - 647 nm 660 nm FC RUO
14-0549 Anti-Human CD54 (ICAM-1) Purified FC, IHC, FA, WB RUO
12-0549 Anti-Human CD54 (ICAM-1) PE 488 - 561 nm 575 nm FC RUO
46-0549 Anti-Human CD54 (ICAM-1) PerCP-eFluor® 710 488 nm 710 nm FC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
16-4714 Mouse IgG1 K Isotype Control Functional Grade Purified FC RUO
References

References: Knapp, W., B. Dorken, et al. eds. 1989. Leucocyte Typing IV: White Cell Differentiation Antigens. Oxford University Press. New York.

Schlossman, S., L. Bloumsell, et al. eds 1995. Leucocyte Typing V: White Cell Differentiation Antigens. Oxford University Press. New York.

Kishimoto, T., H. Kikutani, et al., eds. 1998. Leucocyte Typing VI: White Cell Differentiation Antigens. Garland Publishing Inc. London.

Kanwar JR, Berg RW, et al. 2003. Requirements for ICAM-1 immunogene therapy of lymphoma. Cancer Gene Ther. 10(6):468-76. (WB, PubMed)

Bao J, Sato K, et al. 2001. PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation. Am J Physiol Heart Circ Physiol. 281(6):H2612-8. (WB, PubMed)

Davis DM, Chiu I, et al. 1999. The human natural killer cell immune synapse. Proc Natl Acad Sci U S A. 96(26):15062-7. (IHC, PubMed)